Prodromal symptoms and the duration of untreated psychosis in first episode of psychosis patients: what differences are there between early vs. adult onset and between schizophrenia vs. bipolar disorder?

Adult onset Children and adolescents Prodromal symptoms Prodrome Schizophrenia, bipolar disorder, early onset

Journal

European child & adolescent psychiatry
ISSN: 1435-165X
Titre abrégé: Eur Child Adolesc Psychiatry
Pays: Germany
ID NLM: 9212296

Informations de publication

Date de publication:
07 Apr 2023
Historique:
received: 18 03 2022
accepted: 10 03 2023
entrez: 7 4 2023
pubmed: 8 4 2023
medline: 8 4 2023
Statut: aheadofprint

Résumé

To assess the role of age (early onset psychosis-EOP < 18 years vs. adult onset psychosis-AOP) and diagnosis (schizophrenia spectrum disorders-SSD vs. bipolar disorders-BD) on the duration of untreated psychosis (DUP) and prodromal symptoms in a sample of patients with a first episode of psychosis. 331 patients with a first episode of psychosis (7-35 years old) were recruited and 174 (52.6%) diagnosed with SSD or BD at one-year follow-up through a multicenter longitudinal study. The Symptom Onset in Schizophrenia (SOS) inventory, the Positive and Negative Syndrome Scale and the structured clinical interviews for DSM-IV diagnoses were administered. Generalized linear models compared the main effects and group interaction. 273 AOP (25.2 ± 5.1 years; 66.5% male) and 58 EOP patients (15.5 ± 1.8 years; 70.7% male) were included. EOP patients had significantly more prodromal symptoms with a higher frequency of trouble with thinking, avolition and hallucinations than AOP patients, and significantly different median DUP (91 [33-177] vs. 58 [21-140] days; Z = - 2.006, p = 0.045). This was also significantly longer in SSD vs. BD patients (90 [31-155] vs. 30 [7-66] days; Z = - 2.916, p = 0.004) who, moreover had different profiles of prodromal symptoms. When assessing the interaction between age at onset (EOP/AOP) and type of diagnosis (SSD/BD), avolition was significantly higher (Wald statistic = 3.945; p = 0.047), in AOP patients with SSD compared to AOP BD patients (p = 0.004). Awareness of differences in length of DUP and prodromal symptoms in EOP vs. AOP and SSD vs. BD patients could help improve the early detection of psychosis among minors.

Identifiants

pubmed: 37027026
doi: 10.1007/s00787-023-02196-7
pii: 10.1007/s00787-023-02196-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI08/0208
Organisme : Instituto de Salud Carlos III
ID : PI18/0242
Organisme : Instituto de Salud Carlos III
ID : INT19-00021
Organisme : Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya
ID : 2017SGR1355

Investigateurs

Clemente García-Rizo (C)
Jairo González-Díaz (J)
Mario de Matteis (M)
Héctor de Diego (H)
Eva Grasa (E)
Alejandra Roldán (A)
Iñaki Zorrilla (I)
Edurne García-Corres (E)
Pedro M Ruíz-Lázaro (PM)
Concepción de-la-Cámara (C)
Olga Rivero (O)
María José Escarti (MJ)
Francesc Casanovas (F)
Alba Toll (A)
Norma Verdolini (N)
Maria Sagué-Vilabella (M)
Gisela Sugranyes (G)
Daniel Ilzarbe (D)
Fernando Contreras (F)
Leticia González-Blanco (L)
María Paz García-Portilla (MP)
Miguel Gutierrez (M)
Arantzazu Zabala (A)
Roberto Rodríguez-Jiménez (R)
Luis Sánchez-Pastor (L)
Judith Usall (J)
Anna Butjosa (A)
Edith Pomarol (E)
Salvador Sarró (S)
Angela Ibáñez (A)
Ana Maria Sánchez-Torres (AM)
Vicent Balanzá-Martínez (V)

Informations de copyright

© 2023. The Author(s).

Références

McGorry PD, Killackey E, Yung A (2008) Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry 7:148–156
pubmed: 18836582 pmcid: 2559918 doi: 10.1002/j.2051-5545.2008.tb00182.x
van der Gaag M1, Smit F, Bechdolf A, French P, Linszen DH, Yung AR et al (2013) Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups. Schizophr Res 149:56-62.
Bernardo M, Bioque M (2014) What have we learned from research into first-episode psychosis? Rev Psiquiatr Salud Ment 7:61–63
pubmed: 24793240 doi: 10.1016/j.rpsm.2014.03.001
Fusar-Poli P, Yung AR, McGorry P, van Os J (2014) Lessons learned from the psychosis high-risk state: towards a general staging model of prodromal intervention. Psychol Med 44:17–24
pubmed: 23414600 doi: 10.1017/S0033291713000184
Oliver D, Davies C, Crossland G, Lim S, Gifford G, McGuire P, Fusar-Poli P (2018) Can we reduce the duration of untreated psychosis a systematic review and meta-analyisis of controlled interventional studies. Schiz Bull. https://doi.org/10.1093/schbul/sbx166
doi: 10.1093/schbul/sbx166
McGlashan TH (2006) Is active psychosis neurotoxic? Schizophr Bull 32:609–613
pubmed: 16914639 pmcid: 2632265 doi: 10.1093/schbul/sbl032
Anderson KK, Voineskos A, Mulsant BH, George TP, Mckenzie KJ (2014) The role of untreated psychosis in neurodegeneration: a review of hypothesized mechanisms of neurotoxicity in first-episode psychosis. Can J Psychiatry 59:513–517
pubmed: 25565683 pmcid: 4197784 doi: 10.1177/070674371405901003
Perkins DO, Gu H, Boteva K, Lieberman JA (2005) Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 162:1785–1804
pubmed: 16199825 doi: 10.1176/appi.ajp.162.10.1785
Albert N, Weibell MA (2019) The outcome of early intervention in first episode psychosis. Int Rev Psychiatry 31:413–424
pubmed: 31456455 doi: 10.1080/09540261.2019.1643703
Penttilä M, Jaaskelainen E, Hirvonen N, Isohanni M, Miettunen J (204) Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 205: 88–94.
Clemmensen L, Vernal DL, Steinhausen HC (2012) A systematic review of the long-term outcome of early onset schizophrenia. BMC Psychiatry12:150
Díaz-Caneja CM, Pina-Camacho L, Rodríguez-Quiroga A, Fraguas D, Parellada M, Arango C (2015) Predictors of outcome in early-onset psychosis: a systematic review. NPJ Schizophr 1:14005
pubmed: 27336027 pmcid: 4849440 doi: 10.1038/npjschz.2014.5
Altamura AC, Buoli M, Caldiroli A, Caron L, Cumerlato Melter C et al (2015) Misdiagnosis, duration of untreated illness (DUI) and outcome in bipolar patients with psychotic symptoms: a naturalistic study. J Affect Disord 182:70–75
pubmed: 25978716 doi: 10.1016/j.jad.2015.04.024
McClellan JS, S, (2013) Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adol Psychiatry 52:976–990
doi: 10.1016/j.jaac.2013.02.008
Coulon N, Godin O, Bulzacka E, Dubertret C, Mallet J, Fond G et al (2020) Early and very early-onset schizophrenia compared with adult-onset schizophrenia: French FACE-SZ database. Brain Behav 10:e01495
pubmed: 31908151 pmcid: 7010576 doi: 10.1002/brb3.1495
Ehmann TS, Tee KA, MacEwan GW, Dalzell KL, Hanson LA, Smith GN, Kopala LC, Honer WG (2014) Treatment delay and pathways to care in early psychosis. Early Interv Psychiatry 8:240–246
pubmed: 23682935 doi: 10.1111/eip.12051
Lihong Q, Shimodera S, Fujita H, Morokuma I, Nishida A, Kamimura N et al (2012) Duration of untreated psychosis in a rural/suburban region of Japan. Early Interv Psychiatry 6:239–246
pubmed: 22221408 doi: 10.1111/j.1751-7893.2011.00325.x
Cratsley K, Regan J, McAllister V, Simic M, Aitchison KJ (2008) Duration of untreated psychosis, referral route, and age of onset in an early intervention in psychosis service and a local CAMHS. Child Adolesc Ment Health 13:130–133
pubmed: 32847178 doi: 10.1111/j.1475-3588.2007.00467.x
Souaiby L, Gauthier C, Kazes M, Mam-Lam-Fook C, Daban C, Plaze M et al (2019) Individual factors influencing the duration of untreated psychosis. Early Interv Psychiatry 13:798–804
pubmed: 29575691 doi: 10.1111/eip.12562
Ramain J, Conus P, Golay P (2022) Exploring the clinical relevance of a dichotomy between affective and non-affective psychosis: Results from a first-episode psychosis cohort study. Early Interv Psychiatry 16:168–177
pubmed: 33751798 doi: 10.1111/eip.13143
Large M, Nielssen O, Slade T, Harris A (2008) Measurement and reporting of the duration of untreated psychosis. Early Interv Psychiatry 2:201–211
pubmed: 21352155 doi: 10.1111/j.1751-7893.2008.00080.x
Cerqueira RO, Ziebold C, Cavalcante D, Oliveira G, Vásquez J, Undurraga J et al (2022) Differences of affective and non-affective psychoses in early intervention services from Latin America. J Affect Disord 316:83–90
pubmed: 35961602 doi: 10.1016/j.jad.2022.08.010
Drake RJ, Husain N, Marshall M, Lewis SW, Tomenson B, Chaudhry IB et al (2020) Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes: a longitudinal analysis and modelling study. Lancet Psychiatry 7:602–610
pubmed: 32563307 pmcid: 7606908 doi: 10.1016/S2215-0366(20)30147-4
Kim JS, Baek JH, Choi JS, Lee D, Kwon JS, Hong KS (2011) Diagnostic stability of first-episode psychosis and predictors of diagnostic shift from non-affective psychosis to bipolar disorder: a retrospective evaluation after recurrence. Psychiatry Res 188:29–33
pubmed: 21056477 doi: 10.1016/j.psychres.2010.09.017
Rosen C, Marvin R, Reilly JL, Deleon O, Harris MS, Keedy SK et al (2012) Phenomenology of first-episode psychosis in schizophrenia, bipolar disorder, and unipolar depression: a comparative analysis. Clin Schizophr Relat Psychoses 6:145–151
pubmed: 23006239 doi: 10.3371/CSRP.6.3.6
Salagre E, Grande I, Vieta E, Mezquida G, Cuesta MJ, Moreno C et al (2020) Predictors of Bipolar Disorder Versus Schizophrenia Diagnosis in a Multicenter First Psychotic Episode Cohort: Baseline Characterization and a 12-Month Follow-Up Analysis. J Clin Psychiatry 81:19m12996.
Arango C (2011) Attenuated psychotic symptoms syndrome: how it may affect child and adolescent psychiatry. Eur Child Adolesc Psychiatry 20:67–70
pubmed: 21057834 doi: 10.1007/s00787-010-0144-2
Schimmelmann BG, Michel C, Martz-Irngartinger A, Linder C, Schultze-Lutter F (2015) Age matters in the prevalence and clinical significance of ultra-high-risk for psychosis symptoms and criteria in the general population: Findings from the BEAR and BEARS-kid studies. World Psychiatry 14:189–197
pubmed: 26043337 pmcid: 4471976 doi: 10.1002/wps.20216
Tor J, Dolz M, Sintes A, Muñoz D, Pardo M, de la Serna E et al (2018) Clinical high risk for psychosis in children and adolescents: a systematic review. Eur Child Adolesc Psychiatry 27:683–700
pubmed: 28914382 doi: 10.1007/s00787-017-1046-3
Armando M, Klauser P, Anagnostopoulos D, Hebebrand J, Moreno C, Revet A, Raynaud JP (2020) Clinical high risk for psychosis model in children and adolescents: a joint position statement of ESCAP clinical division and research academy. Eur Child Adolesc Psychiatry 29:413–416
pubmed: 32146537 doi: 10.1007/s00787-020-01499-3
Birmaher B (2016) The challenge of defining prodromal symptoms of schizophrenia and bipolar disorders. Pharmacopsychiatry 49:244–245
pubmed: 30703810 doi: 10.1055/s-0042-115174
Yung AR, McGorry PD (1996) The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 22:353–370
pubmed: 8782291 doi: 10.1093/schbul/22.2.353
Skjelstad DV, Malt UF, Holte A (2010) Symptoms and signs of the initial prodrome of bipolar disorder: a systematic review. J Affect Disord 126:1–13
pubmed: 19883943 doi: 10.1016/j.jad.2009.10.003
Faedda GL, Baldessarini RJ, Marangoni C, Bechdolf A, Berk M, Birmaher B et al (2019) An international society of Bipolar disorders task force report: precursors and prodromes of bipolar disorder. Bipolar Disord 21:720–740
pubmed: 31479581 doi: 10.1111/bdi.12831
Schultze-Lutter F, Schimmelmann BG, Klosterkötter J, Ruhrmann S (2012) Comparing the prodrome of schizophrenia-spectrum psychoses and affective disorders with and without psychotic features. Schizophr Res 138:218–222
pubmed: 22551680 doi: 10.1016/j.schres.2012.04.001
Kafali HY, Bildik T, Bora E, Yuncu Z, Erermis HS (2019) Distinguishing prodromal stage of bipolar disorder and early onset schizophrenia spectrum disorders during adolescence. Psychiatry Res 275:315–325
pubmed: 30953877 doi: 10.1016/j.psychres.2019.03.051
Bernardo M, Bioque M, Parellada M, Sáiz RJ, Cuesta MJ, Llerena A et al (2013) Assessing clinical and functional outcomes in a gen-environmental interaction study in first episode of psychosis. Rev Psiquiatr Salud Ment 6:4–16
pubmed: 23206389 doi: 10.1016/j.rpsm.2012.11.001
Bernardo M, Cabrera B, Arango C, Bioque M, Castro-Fornieles J, Cuesta MJ et al (2019) One decade of the first episodes project: advancing towards a precision psychiatry. Rev Psiquiatr Salud Ment 12:135–140
doi: 10.1016/j.rpsm.2019.03.001
Salagre E, Arango C, Artigas F, Ayuso-Mateos JL, Bernardo M, Castro-Fornieles J et al (2019) CIBERSAM: Ten years of collaborative translational research in mental disorders. Rev Psiquiatr Salud Ment 12:1–8
doi: 10.1016/j.rpsm.2018.10.001
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC
Hollingshead A, Redlich F (1958) Social Class and Mental Illness. Wiley, New York
doi: 10.1037/10645-000
Perkins DO, Leserman J, Jarskog LF, Graham K, Kazmer J, Lieberman JA (2000) Characterizing and dating the onset of symptoms in psychotic illness: the symptom onset in schizophrenia (SOS) inventory. Schizophr Res 44:1–10
pubmed: 10867307 doi: 10.1016/S0920-9964(99)00161-9
Mezquida G, Cabrera B, Martínez-Arán A, Vieta E, Bernardo M (2018) Detection of early psychotic symptoms: Validation of the Spanish version of the “Symptom Onset in Schizophrenia inventory” Psych Res 261:68–72.
First M, Spitzer R, Gibbon M, Willimans J (1997) Structured Clinical Interview for DSM-IV Axis I Disorders. Clinician Version American Medical Association, Washington DC
Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N (1997) Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version : Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980–988
pubmed: 9204677 doi: 10.1097/00004583-199707000-00021
Ulloa RE, Ortiz S, Higuera F, Nogales I, Fresán A, Apiquian R et al (2006) Interrater reliability of the Spanish version of schedule for affective disorders and schizophrenia for school-age children-present and lifetime version. Actas Esp Psiquiatr 34:36–40
pubmed: 16525903
Kay S, Fiszbein A, Opler L (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276
pubmed: 3616518 doi: 10.1093/schbul/13.2.261
Peralta V, Cuesta MJ (1994) Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res 53:31–40
pubmed: 7991730 doi: 10.1016/0165-1781(94)90093-0
Kokkevi A, Hartgers, (1995) EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur Addict Research 1:208–210
doi: 10.1159/000259089
Santesteban-Echarri O, Paino M, Rice S, González-Blanch C, McGorry P, Gleeson J, Alvarez-Jimenez M (2017) Predictors of functional recovery in first-episode psychosis: a systematic review and meta-analysis of longitudinal studies. Clin Psychol Rev 58:59–75
pubmed: 29042139 doi: 10.1016/j.cpr.2017.09.007
Register-Brown K, Hong LE (2014) Reliability and validity of methods for measuring the duration of untreated psychosis: a quantitative review and meta-analysis. Schizophr Res 160:20–26
pubmed: 25464915 doi: 10.1016/j.schres.2014.10.025
Dominguez MD, Fisher HL, Major B, Chisholm B, Rahaman N, Joyce J et al (2013) Duration of untreated psychosis in adolescents: ethnic differences and clinical profiles. Schizophr Res 150:526–532
pubmed: 24025696 doi: 10.1016/j.schres.2013.08.018
Joa I, Johannessen JO, Langeveld J, Friis S, Melle I, Opjordsmoen S et al (2009) Baseline profiles of adolescent vs. adult-onset first-episode psychosis in an early detection program. Acta Psychiatr Scand 119:494–500
pubmed: 19207132 doi: 10.1111/j.1600-0447.2008.01338.x
Ballageer T, Malla A, Manchanda R, Takhar J, Haricharan R (2005) Is adolescent-onset first-episode psychosis different from adult onset? J Am Acad Child Adolesc Psychiatry 44:782–789
pubmed: 16034280 doi: 10.1097/01.chi.0000164591.55942.ea
Norman RM, Malla AK (2002) Examining adherence to medication and substance use as possible confounds of duration of untreated psychosis. J Nerv Ment Dis 190:331–334
pubmed: 12011614 doi: 10.1097/00005053-200205000-00010
Singh SP, Cooper JE, Fisher HL, Tarrant CJ, Lloyd T, Banjo J et al (2005) Determining the chronology and components of psychosis onset: the nottingham onset schedule (NOS). Schizophr Res 80:117–130
pubmed: 15978778 doi: 10.1016/j.schres.2005.04.018
McGlashan TH (1999) Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biol Psychiatry 46:899–907
pubmed: 10509173 doi: 10.1016/S0006-3223(99)00084-0
Ajnakina O, Rodriguez V, Quattrone D, di Forti M, Vassos E, Arango C et al (2021) Duration of untreated psychosis in first-episode psychosis is not associated with common genetic variants for major psychiatric conditions: results from the multi-center EU-GEI Study. Schizophr Bull 47:1653–1662
pubmed: 33963865 pmcid: 8562562 doi: 10.1093/schbul/sbab055
Esterberg M, Comptom M (2012) Family history of psychosis negatively impacts age at onset, negative symptoms, and duration of untreated illness and psychosis in first-episode psychosis patients. Psychiatry Res 197:23–28
pubmed: 22503358 pmcid: 3612976 doi: 10.1016/j.psychres.2012.03.001
Norman RM, Malla AK, Manchanda R (2007) Delay in treatment for psychosis: its relation to family history. Soc Psychiatry Psychiatr Epidemiol 42:507–512
pubmed: 17514375 doi: 10.1007/s00127-007-0174-3
Norman RM, Scholten DJ, Malla AK, Ballageer T (2005) Early signs n schizophrenia spectrum disorders. J Nerv Ment Dis 193:17–23
pubmed: 15674130 doi: 10.1097/01.nmd.0000149214.17924.d9
Murray RM, Bhavsar V, Tripoli G (2017) Howes O (2017) 30 years on: how the neurodevelopmental hypothesis of Schizophrenia morphed into the developmental risk factor model of psychosis. Schizophr Bull 43:1190–1196
pubmed: 28981842 pmcid: 5737804 doi: 10.1093/schbul/sbx121
Sugranyes G, de la Serna E, Borras R, Sanchez-Gistau V, Pariente JC, Romero S et al (2017) Clinical, cognitive, and neuroimaging evidence of a neurodevelopmental continuum in offspring of probands With Schizophrenia and Bipolar disorder. Schizophr Bull 43:1208–1219
pubmed: 28180904 pmcid: 5737486 doi: 10.1093/schbul/sbx002
Baeza I, de la Serna E, Amoretti S, Cuesta MJ, Díaz-Caneja CM, Mezquida G et al (2021) Premorbid Characteristics as Predictors of Early Onset Versus Adult Onset in Patients With a First Episode of Psychosis. J Clin Psychiatry 82:21m13907.
Jalbrzikowski M, Hayes RA, Wood SJ, Nordholm D, Zhou JH, Fusar-Poli P et al (2021) Association of structural magnetic resonance imaging measures with psychosis onset in individuals at clinical high risk for developing psychosis: an ENIGMA working group mega-analysis. JAMA Psychiat 78:753–766
doi: 10.1001/jamapsychiatry.2021.0638
Maibing CF, Pedersen CB, Benros ME, Mortensen PB, Dalsgaard S, Nordentoft M (2015) Risk of schizophrenia increases after all child and adolescent psychiatric disorders: a nationwide study. Schizophr Bull 41:963–970
pubmed: 25193974 doi: 10.1093/schbul/sbu119
Engqvist U, Rydelius PA (2008) The occurrence and nature of early signs of schizophrenia and psychotic mood disorders among former child and adolescent psychiatric patients followed into adulthood. Child Adolesc Psychiatry Ment Health 2:30
pubmed: 18928534 pmcid: 2583965 doi: 10.1186/1753-2000-2-30
Jackson HJ, McGorry PD, Dudgeon P (1995) Prodromal symptoms of schizophrenia in first-episode psychosis: prevalence and specificity. Compr Psychiatry 36:241–250
pubmed: 7554867 doi: 10.1016/S0010-440X(95)90068-3
Gourzis P, Katrivanou A, Beratis S (2002) Symptomatology of the initial prodromal phase in schizophrenia. Schizophr Bull 28:415–429
pubmed: 12645674 doi: 10.1093/oxfordjournals.schbul.a006950
Conus P, Ward J, Hallam KT, Lucas N, Macneil C, McGorry PD, Berk M (2008) The proximal prodrome to first episode mania–a new target for early intervention. Bipolar Disord 10:555–565
pubmed: 18657240 doi: 10.1111/j.1399-5618.2008.00610.x
Van Meter AR, Burke C, Youngstrom EA, Faedda GL, Correll CU (2016) The bipolar prodrome: meta-analysis of symptom prevalence prior to initial or recurrent mood episodes. J Am Acad Child Adolesc Psychiatry 55:543–555
pubmed: 27343882 doi: 10.1016/j.jaac.2016.04.017
Correll CU, Penzner JB, Frederickson AM, Richter JJ, Auther AM, Smith CW et al (2007) Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome. Schizophr Bull 33:703–714
pubmed: 17478437 pmcid: 2526140 doi: 10.1093/schbul/sbm028
Olvet DM, Stearns WH, McLaughlin D, Auther AM, Correll CU, Cornblatt BA (2010) Comparing clinical and neurocognitive features of the schizophrenia prodrome to the bipolar prodrome. Schizophr Res 123:59–63
pubmed: 20716479 pmcid: 2939255 doi: 10.1016/j.schres.2010.07.005
Kirkpatrick B, Fenton W S, Carpenter W T Jr, Marder S R (2006) The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull 32, 214–219
Strauss GP, Bartolomeo LA, Harvey PD (2021) Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development. NPJ Schizophr 26(7):16
doi: 10.1038/s41537-021-00145-4
Correll CU, Schooler NR (2020) Negative symptoms in Schizophrenia: a review and clinical guide for recognition, assessment, and treatment. Neuropsychiatr Dis Treat 16:519–534
pubmed: 32110026 pmcid: 7041437 doi: 10.2147/NDT.S225643
Mezquida G, Cabrera B, Bioque M, Amoretti S, Lobo A, González-Pinto A et al (2017) The course of negative symptoms in first-episode schizophrenia and its predictors: a prospective two-year follow-up study. Schizophr Res 189:84–90
pubmed: 28185786 doi: 10.1016/j.schres.2017.01.047
Levi L, Haim MB, Burshtein S, Winter-Van Rossum I, Heres S, Davidson M et al (2020) Duration of untreated psychosis and response to treatment: an analysis of response in the OPTiMiSE cohort. Eur Neuropsychopharmacol 32:131–135
pubmed: 32037127 doi: 10.1016/j.euroneuro.2020.01.007

Auteurs

Inmaculada Baeza (I)

Child and Adolescent Psychiatry and Psychology Department, Hospital Clínic de Barcelona, 2021SGR01319, Barcelona, Spain. ibaeza@clinic.cat.
Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM-ISCIII, Madrid, Spain. ibaeza@clinic.cat.
Institut d'Investigacions Biomèdiques August Pi Sunyer (CERCA-IDIBAPS), Barcelona, Spain. ibaeza@clinic.cat.
Department of Medicine, Universitat de Barcelona, Barcelona, Spain. ibaeza@clinic.cat.

Elena de la Serna (E)

Child and Adolescent Psychiatry and Psychology Department, Hospital Clínic de Barcelona, 2021SGR01319, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM-ISCIII, Madrid, Spain.

Gisela Mezquida (G)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM-ISCIII, Madrid, Spain.
Department of Medicine, Universitat de Barcelona, Barcelona, Spain.
Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain.

Manuel J Cuesta (MJ)

Department of Psychiatry, Complejo Hospitalario de Navarra, Pamplona. IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.

Eduard Vieta (E)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM-ISCIII, Madrid, Spain.
Institut d'Investigacions Biomèdiques August Pi Sunyer (CERCA-IDIBAPS), Barcelona, Spain.
Department of Medicine, Universitat de Barcelona, Barcelona, Spain.
Bipolar and Depressive Disorder Unit, Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain.

Silvia Amoretti (S)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM-ISCIII, Madrid, Spain.
Department of Medicine, Universitat de Barcelona, Barcelona, Spain.
Bipolar and Depressive Disorder Unit, Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain.
Group of Psychiatry, Psychiatric Genetics Unit, Mental Health and Addictions, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.

Antonio Lobo (A)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM-ISCIII, Madrid, Spain.
Department of Medicine and Psychiatry, Hospital Clínico Universitario and Instituto de Investigación Sanitaria (IIS) Aragón, Universidad de Zaragoza, Zaragoza, Spain.

Ana González-Pinto (A)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM-ISCIII, Madrid, Spain.
Department of Psychiatry, Hospital Universitario de Alava, BIOARABA, EHU, Vitoria, Spain.

Covadonga M Díaz-Caneja (CM)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM-ISCIII, Madrid, Spain.
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, School of Medicine, Hospital General Universitario Gregorio Marañón, Universidad Complutense, IiSGM, Madrid, Spain.

Iluminada Corripio (I)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM-ISCIII, Madrid, Spain.
Psychiatry Department, Institut d'Investigació Biomèdica-Sant Pau (IIB-SANT PAU), Hospital de La Santa Creu I Sant Pau, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.

Isabel Valli (I)

Institut d'Investigacions Biomèdiques August Pi Sunyer (CERCA-IDIBAPS), Barcelona, Spain.
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Olga Puig (O)

Child and Adolescent Psychiatry and Psychology Department, Hospital Clínic de Barcelona, 2021SGR01319, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM-ISCIII, Madrid, Spain.
Department of Medicine, Universitat de Barcelona, Barcelona, Spain.

Anna Mané (A)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM-ISCIII, Madrid, Spain.
Hospital del Mar Medical Research Institute (IMIM), Pompeu Fabra University, Barcelona, Spain.

Miquel Bioque (M)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM-ISCIII, Madrid, Spain.
Institut d'Investigacions Biomèdiques August Pi Sunyer (CERCA-IDIBAPS), Barcelona, Spain.
Department of Medicine, Universitat de Barcelona, Barcelona, Spain.
Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain.

Miriam Ayora (M)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM-ISCIII, Madrid, Spain.
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, School of Medicine, Hospital General Universitario Gregorio Marañón, Universidad Complutense, IiSGM, Madrid, Spain.

Miquel Bernardo (M)

Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM-ISCIII, Madrid, Spain.
Institut d'Investigacions Biomèdiques August Pi Sunyer (CERCA-IDIBAPS), Barcelona, Spain.
Department of Medicine, Universitat de Barcelona, Barcelona, Spain.
Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain.

Josefina Castro-Fornieles (J)

Child and Adolescent Psychiatry and Psychology Department, Hospital Clínic de Barcelona, 2021SGR01319, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM-ISCIII, Madrid, Spain.
Institut d'Investigacions Biomèdiques August Pi Sunyer (CERCA-IDIBAPS), Barcelona, Spain.
Department of Medicine, Universitat de Barcelona, Barcelona, Spain.

Classifications MeSH